Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.1% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOC
2001
DELISTED
Biocept, Inc.
BIOC
| $2.7M | ﹤0.01% |
12,655
+6,574
| +108% | +$943K |
|
2002
Navigator Holdings
NVGS
$1.38B
| $2.69M | ﹤0.01% |
419,100
-206,508
| -33% | -$1.29M |
|
2003
TTM Technologies
TTMI
$12B
| $2.69M | ﹤0.01% |
+227,269
| New | +$2.53M |
|
2004
iShares Russell 1000 Value ETF
IWD
$82.6B
| $2.68M | ﹤0.01% |
+23,800
| New | +$2.62M |
|
2005
Larimar Therapeutics
LRMR
$397M
| $2.68M | ﹤0.01% |
208,574
+28,528
| +16% | +$332K |
|
|
EGIO
2006
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.68M | ﹤0.01% |
9,102
+7,695
| +547% | +$1.71M |
|
2007
LGL Group
LGL
$45.2M
| $2.67M | ﹤0.01% |
832,447
+76,142
| +10% | +$246K |
|
2008
Curis
CRIS
$9.78M
| $2.67M | ﹤0.01% |
5,510
+1,479
| +37% | +$545K |
|
|
STEL
2009
DELISTED
Stellar Bancorp
STEL
| $2.67M | ﹤0.01% |
126,910
+11,700
| +10% | +$217K |
|
2010
InterContinental Hotels
IHG
$23.9B
| $2.66M | ﹤0.01% |
59,983
-112,774
| -65% | -$5.1M |
|
2011
Kforce
KFRC
$1.02B
| $2.65M | ﹤0.01% |
90,649
+77,249
| +576% | +$2.25M |
|
|
AIOT
2012
PowerFleet Inc
AIOT
$526M
| $2.65M | ﹤0.01% |
573,249
+88,020
| +18% | +$409K |
|
2013
ICF International
ICFI
$1.46B
| $2.64M | ﹤0.01% |
+40,700
| New | +$2.67M |
|
2014
Vulcan Materials
VMC
$34.8B
| $2.64M | ﹤0.01% |
+22,765
| New | +$2.49M |
|
2015
Comp X International
CIX
$349M
| $2.63M | ﹤0.01% |
190,646
+2,846
| +2% | +$40.6K |
|
|
TGH
2016
DELISTED
Textainer Group Holdings limited
TGH
| $2.63M | ﹤0.01% |
321,000
-263,300
| -45% | -$2.16M |
|
2017
MSC Industrial Direct
MSM
$6.89B
| $2.62M | ﹤0.01% |
36,000
+28,100
| +356% | +$1.81M |
|
|
PFBI
2018
DELISTED
Premier Financial Bancorp
PFBI
| $2.62M | ﹤0.01% |
204,187
-48,101
| -19% | -$596K |
|
|
CDR
2019
DELISTED
Cedar Realty Trust, Inc
CDR
| $2.62M | ﹤0.01% |
400,483
-57,322
| -13% | -$352K |
|
2020
ePlus
PLUS
$2.42B
| $2.62M | ﹤0.01% |
74,000
+55,600
| +302% | +$1.9M |
|
|
HA
2021
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.61M | ﹤0.01% |
186,200
+23,100
| +14% | +$315K |
|
|
MANT
2022
DELISTED
Mantech International Corp
MANT
| $2.61M | ﹤0.01% |
38,100
+7,600
| +25% | +$559K |
|
|
TBI
2023
Trueblue
TBI
$215M
| $2.6M | ﹤0.01% |
170,600
+130,900
| +330% | +$1.94M |
|
2024
Kadant
KAI
$3.63B
| $2.6M | ﹤0.01% |
26,100
-4,700
| -15% | -$418K |
|
|
PMD
2025
DELISTED
Psychemedics Corporation
PMD
| $2.6M | ﹤0.01% |
468,454
+24,816
| +6% | +$139K |
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.